Clinical trials
catalyst calendar across sponsors →Studies where TMCI is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
3 interventional · 1 observational · 1 with posted results
Held by 10 tracked-famous managers (AQR CAPITAL MANAGEMENT LLC, MARSHALL WACE, LLP, MILLENNIUM MANAGEMENT LLC, D. E. Shaw & Co., Inc., CITADEL ADVISORS LLC, +5 more) · FINRA short interest 5.5 days to cover (settled 2026-07-31) · insider 90d: 8 buys / 0 sells · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Readout in | Updated |
|---|---|---|---|---|---|---|---|---|
| Outcomes Following Combined Adductoplasty™ and Lapiplasty® (MTA3D)NCT05587569Radiographic recurrence of hallux valgus deformity with metatarsus adductus will be evaluated at 24 months for subjects wtih successful correctionOpen-label · Treatment | Not applicable | Recruiting | Device: Treatment of metatarsus adductus and hallux valgus with the Adductoplasty™ Procedure in combination with the Lapiplasty® Procedure | Metatarsus Adductus, Hallux Valgus | 80 | 2026-12-31 | in 133 d | 2025-05-25 |
| The SpeedPlate™ Rapid Compression Implant Study (The SPRINT™ Study)NCT06548581observationalEvaluate union vs non-union | — | Active, not recruiting | Device: SpeedPlate™ Rapid Compression Implants | Joint Arthrodesis, Joint Fixation | 92 | Mar 2026 | — | 2025-06-11 |
| Early Weight-Bearing After the Lapiplasty ProcedureNCT03740282Radiographic recurrence of hallux valgusOpen-label · Treatment | Not applicable | Active, not recruiting | Device: Lapiplasty | Hallux Valgus, Bunion | 183 | 2023-05-01actual | — | 2026-04-06 |
| Early Weight-Bearing After the Lapiplasty Mini-Incision Procedure (Mini3D)NCT05082012results2026-04-20Radiographic RecurrenceOpen-label · TreatmentStudy Protocol ↗ · Statistical Analysis Plan ↗ | Not applicable | Terminatedsponsor's stated reason: Corporate decision to early term study to prepare for publication and addition of new studies | Device: Treatment of Hallux Valgus | Hallux Valgus, Bunion | 123 | 2024-05-09actual | — | 2026-04-20 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19